The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms

Table 3 Clinical features of 10 myeloproliferative neoplasm patients with JAK2 Exon 12 mutations

Patient no.	Clinical diagnosis	Age	Gender	JAK2 Exon 12 mutation	WBC (10E9/L)	RBC (10E12/L)	Hb (g/L)	PLT (10E9/L)
J2	PV	44	Male	F537-I546dup10/F547L	14.25	3.94	161	438
J23	PV	60	Male	N533D	9.93	4.45	153	136
J27	PV with splenomegaly	44	Female	F537L	N/A*
J32	PV	43	Male	K539L	7.57	5.83	182	159
J41	PV	35	Male	M532V/E543G	8.33	5.72	180	192
J43	PV with recurrent brain stem hemorrhage	47	Male	D544N	9.11	3.86	112	494
J50	PV	44	Male	E543G	14.46	5.1	166	257
J71	PV	41	Female	N542-E543del	6.46	4.14	143	293
J207	PV	43	Female	H538K539delinsL	5.85	5.81	178	85
J254	PV	23	Female	M535I/H538Y/K539I	7.08	7.46	216	151

*Complete blood count was not available as the patient was in an impaired hematopoiesis condition

ISSN: 1756-8722